الولايات المتحدة · منصات وبيانات · Stocktwits

Sellas To Present SLS009 Data At American Society of Hematology – Initial Results Of Therapy In Newly Diagnosed AML Patients Expected In Q4

نشره Stocktwits · الولايات المتحدة منذ 8 س

Sellas Life Sciences (SLS) was in the spotlight on Wednesday after the biotech firm said it will present Phase 2 results for its experimental blood cancer treatment SLS009 at the…

اقرأ المقال كاملًا على Stocktwits سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (stocktwits.com)

يستحق القراءة أيضًا

The Motley Fool

Avis (CAR) Q3 2026 Earnings Call Transcript

MarketWatch

Hospital stocks rally while drugmakers brace for scrutiny. Here’s what the Democratic wave means for healthcare.

CNBC

10-year Treasury yield slides as traders mull over Democrats' midterm victories, oil prices drop

Investing.com

Curtiss-Wright stock hits 52-week low at 453.32 USD

Benzinga

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

TipRanks